Dr. Dan Hartman joined the foundation in 2012 as the director of Integrated Development and leads a team that provides technical expertise in drug and diagnostic development. Under his leadership, Integrated Development works closely with the foundation’s strategy teams to manage product pipelines through clinical trials as well as provide help with manufacturing, compliance, and regulatory strategy/intelligence. In this role, Dan is engaged in many of the malaria team’s projects, particularly in product development and is currently also serving as Interim Director for the Malaria team.
Dr. Hartman has extensive management and pharmaceutical experience and joined the foundation after four years as President and CEO of Great Lakes Development Inc.--a consulting company providing strategic and operational support for early drug development projects. Previously, Dr. Hartman served as Senior Vice President of Product Development at deCODE genetics, Executive Director of Pfizer Global Research and Development, Vice President of Global Clinical Development at Esperion Therapeutics, and senior clinical research positions at Eli Lilly & Company in addition to being a member of the Scientific Medical Advisory Board at Hopen Life Sciences Venture Fund.
Dr. Hartman received his bachelor’s degree from Calvin College and his medical degree from Wayne State University. He trained in internal medicine and completed a fellowship in pulmonary medicine at Indiana University where he also was chief medical resident.